FOLD — AMICUS THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  9 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2021 Q3)
Avg. % of fund
0.05%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 65,467 -41,306 -38.7% 0.03% $516K $7.88
2025 Q1 ADDED 106,773 +68,245 +177.1% 0.04% $871K $8.16
2024 Q4 ADDED 38,528 +594 +1.6% 0.03% $363K $9.42
2024 Q3 ADDED 37,934 +26,925 +244.6% 0.03% $405K $10.68
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% Bellevue Group AG 3Y 7Y 2.9% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75%
← Back to XTX Topco Ltd Holdings